Product Information
CARBAMAZEPINE 100 MG TAB CHEW is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2426 per EA under NDC 51672404101. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 24, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672404101
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA075687FDA Approved
10/24/2000
TE Code
AB
On Market Since
10/24/2000
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 100 MG TAB CHEW has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 329.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2426 per EA |
|---|---|
| All-time high | $0.4245 (Apr 13, 2016) |
| All-time low | $0.0565 (Nov 28, 2013) |
| 52-week high | $0.2567 |
| 52-week low | $0.2395 |
| Median price | $0.3035 |
| Average price | $0.2948 |
| Largest weekly change | +368.3% (Jul 16, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbamazepine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Mood Stabilizer class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 100 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 100 MG TAB CHEW, manufactured by Sun Pharmaceutical Industries Inc., is $0.2426 per EA (NDC 51672404101), effective Sep 30, 2026.
How has the price of CARBAMAZEPINE 100 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 100 MG TAB CHEW has risen 329.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 100 MG TAB CHEW?
Since Nov 28, 2013, the NADAC for CARBAMAZEPINE 100 MG TAB CHEW has ranged from a low of $0.0565 (Nov 28, 2013) to a high of $0.4245 (Apr 13, 2016), with a median of $0.3035 per EA.
Are there cheaper alternatives to CARBAMAZEPINE 100 MG TAB CHEW?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE ER 100 MG TABLET, is $0.1989 per EA — about 18% below CARBAMAZEPINE 100 MG TAB CHEW.
Who manufactures CARBAMAZEPINE 100 MG TAB CHEW?
CARBAMAZEPINE 100 MG TAB CHEW (NDC 51672404101) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.